Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma

Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma

Background: Glioma, a highly resistant and recurrent type of central nervous system tumor, poses a significant challenge in terms of effective drug treatments and its associated mortality rates. Despite the discovery of Ferredoxin 1 (FDX1) as a crucial participant in cuproptosis, an innovative mecha...

Full description

Bibliographic Details
Main Authors: Dongcheng Xie, Hailong Huang, Youwei Guo, Zhipeng Jiang, Yirui Kuang, Haoxuan Huang, Weidong Liu, Lei Wang, Zhaoqi Xin, Binbin Wang, Caiping Ren, Xingjun Jiang
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
FDX1
Glioma
Prognosis
Malignant phenotype
Biomarker
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402403007X

Internet

http://www.sciencedirect.com/science/article/pii/S240584402403007X

Similar Items